A detailed history of Mengis Capital Management, Inc. transactions in Bruker Corp stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 56,035 shares of BRKR stock, worth $3.2 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
56,035
Previous 59,540 5.89%
Holding current value
$3.2 Million
Previous $3.8 Million 1.84%
% of portfolio
0.78%
Previous 0.78%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$60.3 - $70.67 $211,351 - $247,698
-3,505 Reduced 5.89%
56,035 $3.87 Million
Q2 2024

Aug 13, 2024

BUY
$63.57 - $92.93 $181,174 - $264,850
2,850 Added 5.03%
59,540 $3.8 Million
Q2 2019

Jul 18, 2019

BUY
$37.48 - $49.95 $2.12 Million - $2.83 Million
56,690 New
56,690 $2.83 Million

Others Institutions Holding BRKR

About BRUKER CORP


  • Ticker BRKR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 148,138,000
  • Market Cap $8.45B
  • Description
  • Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...
More about BRKR
Track This Portfolio

Track Mengis Capital Management, Inc. Portfolio

Follow Mengis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mengis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mengis Capital Management, Inc. with notifications on news.